White Brook Capital's Q3 2026 investor letter expresses cautious optimism. Its Ethical All-Cap Strategy has outperformed, while the Small Cap Strategy has lagged because of execution delays, higher interest rates, and market pressure. You can download a copy of the letter here . The economy remains resilient, supported by AI infrastructure investment, consumer spending, healthcare research, transportation, and construction, but rising rates, energy and labor costs, fiscal deficits, trade conflicts, and geopolitical tensions are raising questions. White Brook's AI thesis is "yet": AI has not fundamentally transformed employment, education, corporate margins, or global competition, although its impact may accelerate. The firm favors AI infrastructure providers such as Nvidia, TSMC, SK Hynix, and Qnity over expensive frontier-model developers. It also identifies opportunities in media, streaming, healthcare technology, industrials, specialty chemicals, nuclear-waste treatment, and siRNA manufacturing. The Ethical Large Cap Index remains a long-term ethical alternative to the S&P 500. Additionally, reviewing the Strategy's top five holdings provides insight into its best positions for 2026.
In its Q3 2026 investor letter, White Brook Capital highlighted CareCloud, Inc. (NASDAQ: CCLD ). CareCloud, Inc. (NASDAQ:CCLD) is a healthcare information technology company that provides software and services to healthcare organizations, including medical billing, revenue cycle management, electronic health records, and patient engagement tools. On October 21, 2026, CareCloud, Inc. (NASDAQ:CCLD) closed at $1.77, with a $75.21 million market capitalization. CareCloud, Inc. (NASDAQ:CCLD) posted a 39.38% YTD pullback, trading within a 52-week range of $1.73 to $3.81.
White Brook Capital stated the following regarding CareCloud, Inc. (NASDAQ:CCLD) in its Q3 2026 investor letter:
"CareCloud, Inc. (NASDAQ:CCLD) sells billing, medical-records, and AI software to doctors and hospitals. We believe the market's frustration is declining profits as the company absorbs acquisitions. Second-quarter revenue grew 16%, but net income fell to only $1.1 million because of merger costs, heavier AI spending, and interest on new debt while a March cyberattack created a further headache. Management expects insurance to cover the costs, but it shook investor confidence. The company also retired the preferred stock we previously owned in May, saving about $3.3 million annually. Management expects a stronger second half than first. At roughly eight times the midpoint of management's 2026 GAAP earnings-per-share guidance, CareCloud offers double-digit revenue growth at a modest earnings multiple, with additional upside if acquisition integration improves margins."
CareCloud, Inc. (NASDAQ:CCLD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds . As per our database, 8 hedge fund portfolios held CareCloud, Inc. (NASDAQ:CCLD) at the end of the second quarter, which was 14 in the previous quarter. While we acknowledge the potential of CareCloud, Inc. (NASDAQ:CCLD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
In another article , we discussed CareCloud, Inc. (NASDAQ:CCLD) and shared Bilbel Capital's views on the company. In addition, please check out our hedge fund investor letters Q3 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years .
